An observational study in Cystic Fibrosis, Asthma and COPD, sponsored by Hôpital Haut Lévêque. Active, not recruiting at 1 site in France. Open to participants aged 3 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-01-05.
Sponsored by Hôpital Haut Lévêque · Observational
Lung structural abnormalities are complex, time-consuming, and may lack reproducibility to evaluate visually on CT scans. The study's aim is to perform automated recognition of structural abnormalities in CT scans of patients with chronic lung diseases by using dedicated software.
Three chronic lung diseases will constitute the target of the study, by using retrospective data from each lung disease:
Dedicated algorithms will be developped for each disease condition.
1,581 studies on the registry are indexed under Cystic Fibrosis; 190 are open to participants now.
This study's planned enrollment of 800 is above the median of 85 across 482 observational studies indexed under Cystic Fibrosis.
Browse Cystic Fibrosis studies →Hôpital Haut Lévêque is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with chronic lung disease and a Clinical examination, pulmonary function test, and CT acquired during an annual routine follow-up
Inclusion Criteria:
This group is dedicated to developing an automated algorithm
Other: Observational study
This group is dedicated to testing the semantic performance of an automated algorithm
Other: Observational study
Patients groups are dedicated to assessing the clinical validity of the measurement in independent validation cohorts, with or without longitudinal evaluations such as monitoring of a treatment effect
Other: Observational study
Validity of automated measurement
Correlations and comparisons with other biomarker of the disease severity
Time frame: From date of inclusion until the date of final quantification, assessed up to 12 months
Correlation with pulmonary function test
Correlation of quantitative measurement with pulmonary function
Time frame: From date of inclusion until the date of final quantification, assessed up to 12 months
Longitudinal variation over time
Comparison of quantitative measurement at two time points
Time frame: From date of inclusion until the date of final quantification, assessed up to 12 months
Reproducibility
Evaluation of measurements when performed twice
Time frame: From date of inclusion until the date of final quantification, assessed up to 12 months
Plan to share: Undecided — Automated software measurements
This study is active, not recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hôpital Haut Lévêque